Better Therapeutics, Inc.

Better Therapeutics, Inc. (Nasdaq: BTTX) is a prescription digital therapeutics company that entered public markets through a merger with Mountain Crest Acquisition Corp. II, a blank-check company sponsored by Mountain Crest Capital LLC that filed its S-1 registration in December 2020. The SPAC targeted the digital health and cardiometabolic disease sector, where Better Therapeutics develops software-based prescription treatments intended to address the root behavioral causes of conditions such as type 2 diabetes. Following the merger's close in 2021, BTTX traded on Nasdaq before the company encountered ongoing operational headwinds. For full filing history, financial data, and current status on BTTX and thousands of other SPAC transactions, sign up for complete access at SpacDesk.